Literature DB >> 4537740

Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer.

I Djerassi, C J Rominger, J S Kim, J Turchi, U Suvansri, D Hughes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4537740     DOI： 10.1002/1097-0142(197207)30:1<22::aid-cncr2820300105>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  20 in total

1.  Methotrexate (MTX) concentration in tumors following low-dose MTX.

Authors:  N J Winick; B A Kamen; A Streckfuss; J Craig; F McGuirt; R L Capizzi; F Sklar; D Coln
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  High-dose methotrexate with citrovorum factor rescue in non-small-cell lung cancer.

Authors:  F A Greco; M F Fer; R L Richardson; K R Hande; C J Van Boxtel; R K Oldham
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 3.  Clinical pharmacokinetics of methotrexate.

Authors:  D D Shen; D L Azarnoff
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

4.  Potentiation of solid-tumor chemotherapy by metabolic alteration.

Authors:  J A Meyer
Journal:  Ann Surg       Date:  1974-01       Impact factor: 12.969

Review 5.  Clinical relevance of pharmacokinetics.

Authors:  G Tognoni; C Bellantuono; M Bonati; M D'Incalci; M Gerna; R Latini; M Mandelli; M G Porro; E Riva
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

6.  [High-dose methotrexate/leucovorin adjuvant chemotherapy of osteogenic sarcoma: biochemical effects in DNA-synthesis of bone marrow cells (author's transl)].

Authors:  H Sauer; W Wilmanns
Journal:  Blut       Date:  1978-06-20

7.  A microbiological assay for the measurement of methotrexate in biological fluids.

Authors:  G C Icke; R E Davis; J Thom
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

8.  Pharmacokinetic and clinical studies of 24-h infusions of high-dose methotrexate.

Authors:  H J Cohen; N Jaffe
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

9.  The inability of oral leucovorin to elevate CSF 5-methyl-tetrahydrofolate following high dose intravenous methotrexate therapy.

Authors:  J Allen; G Rosen; H Juergens; B Mehta
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

10.  [Suppression of cytostatic effect of amethopterin (methotrexate) with methyltetrahydrofolic acid].

Authors:  H Sauer; L Jaenicke
Journal:  Blut       Date:  1974-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.